~~<i id='3F2A5CF03A'><strike id='3F2A5CF03A'><tt id='3F2A5CF03A'><pre id='3F2A5CF03A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：Wikipedia 2025-09-10 15:14:50 - browse：97554

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Boston hospital trains restaurant workers on naloxone for overdoses

hotspot

focus

hotspot

knowledge

focus

JanetWoodcock,theFDA'sprincipaldeputycommissionerChipSomodevilla/GettyImagesWASHINGTON—It’stheendofa

WSS

Oak Street deal isn't the answer to health care's woes

Cognito secures funding to test medical device for Alzheimer's

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Covid misinformation case heads to Supreme Court

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Novo Nordisk to expand supply of Wegovy for U.S. patients

hotspot

entertainment

hotspot

Medical records are filled with copy

Boston hospital trains restaurant workers on naloxone for overdoses

Peter Hotez and the public health issue of online harassment

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Peter Hotez and the public health issue of online harassment

Time to name cancers by genetics, not organ of origin, expert says

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Anesthesiologist group: stop taking Ozempic before surgery

Biden administration opens offers in Medicare drug price negotiations

focus

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Congressmen charge Covid hearing ‘could have been an email’

Cherokee Nation medical school graduates its first class

Do digital therapeutics have a future in medicine?

Novo Nordisk testing Wegovy against alcohol

focus

hotspot

knowledge

focus